The CLINITEK AUWi PRO Automated Urinalysis System 4 is a true walkaway solution for integrated urinalysis testing. It combines a urine chemistry analyzer (CLINITEK Novus Automated Urine Chemistry Analyzer) with a urine sediment analyzer (Sysmex UF-1000i Automated Urine Particle Analyzer).New infectious disease assays include the ADVIA Centaur HIV Ag/Ab Combo (CHIV) assay, which allows for sensitive and specific detection of HIV p24 antigen and antibodies and may improve detection of early acute infections. The ADVIA Centaur Syphilis assay is used as an aid in the disease's diagnosis. This assay allows for sensitive and specific detection of antibodies to Treponema pallidum in human serum or plasma (EDTA, lithium or sodium heparinized, sodium citrate) . In molecular testing, experts will be on hand to discuss the Siemens Tissue Preparation Solution, a single fully-automated solution and reproducible and standardized process for the extraction of high-quality nucleic acid from formalin-fixed paraffin-embedded (FFPE) and fresh frozen (FF) tissues . This solution is enabling technology for the next generation of molecular diagnostics, including next-generation sequencing for infectious disease and oncology testing. Another innovative offering making its debut at AACC is Siemens PEPconnect, part of the total Personalized Education Plan (PEP), 5 the industry's first personalized education and performance experience for the healthcare professional. With optimized technology and increased search capabilities, PEPconnect allows customers to access education and real-time performance support virtually anytime, anywhere, and on any device, including PCs, laptops, tablets, and smartphones. It enables users to construct a personalized learning experience and easily share and connect with others in their workgroup community. For more information about Siemens at AACC, including the company's sponsored educational workshops on chronic kidney disease and Centers for Disease Control (CDC) recommendations for syphilis and hepatitis C testing, scientific posters, and in-booth clinical presentations, please visit www.siemens.com/aacc. 1. Not available for sale in the U.S. Product availability varies by country.2. Under FDA review. Not available for sale in the U.S.3. Not all parameters are available in the U.S. Product availability varies by country.4. Available in the U.S., Canada, and Puerto Rico.5. Patent pending.
The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Further details are available from the local Siemens organizations.Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of combined cycle turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment - such as computed tomography and magnetic resonance imaging systems - and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2014, which ended on September 30, 2014, Siemens generated revenue from continuing operations of €71.9 billion and net income of €5.5 billion. At the end of September 2014, the company had around 343,000 employees worldwide on a continuing basis. Further information is available on the Internet at http://www.siemens.com.